FIG 5.

Median HHV-6B BALF viral loads stratified by the receipt of antivirals before the BAL. (A) Among subjects with HHV-6B⁺ BALF, individuals who received anti–HHV-6B antivirals within 3 days before the BAL had significantly lower median HHV-6B BALF viral loads (2.6 log₁₀ copies/mL) compared with individuals not receiving anti–HHV-6B antivirals (3.4 log₁₀ copies/mL) . (B) Among seven subjects and 12 subjects who did and did not receive anti–HHV-6B antivirals in between subsequent BALs, respectively, there was a greater decrease in the HHV-6B BALF viral load in the subjects receiving antivirals. Only subsequent BALF samples within 28 days of the first HHV-6B⁺ BALF were considered. The boxes represent the interquartile range, the horizontal lines within the boxes represent the median, and the upper and lower whiskers extend to the third and first quartiles ± 1.5 times the interquartile range, respectively. Circles represent data points that fall outside these parameters.